Emerging Markets

© Getty Images

Nucleus RadioPharma secures Series A investment from AstraZeneca

By Isabel Cameron

Nucleus RadioPharma, a leading player in the development, manufacturing, and supply chain management of radiopharmaceuticals, has announced a significant milestone with the closing of a Series A extension round, featuring a new investment from AstraZeneca.

© Getty Images

Bio International 2024

Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024

By Isabel Cameron

Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at Ecolab Life Sciences to find out what the company is planning for the event and how it is navigating current challenges...

© Getty Images

Bio International 2024

Novartis to showcase next-gen manufacturing solutions at BIO 2024

By Isabel Cameron

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head business development at Novartis Contract Manufacturing. At the event, the company will be showcasing its cutting-edge technologies,...

© Enhanc3D Genomics

How Hazel Jones is charting new horizons in genomics

By Isabel Cameron

Hazel Jones is the CEO at Enhanc3D Genomics. We sat down with her to discuss her leap of faith into 3D genomics, and how she is scaling the business and driving operational change.

© Getty Images

Nature Immunology spotlights Alchemab's cancer therapy potential

By Isabel Cameron

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, has published a peer-reviewed article titled "Predictability of B cell clonal persistence and immunosurveillance in breast...